228 related articles for article (PubMed ID: 17702741)
1. High affinity binding of epibatidine to serotonin type 3 receptors.
Drisdel RC; Sharp D; Henderson T; Hales TG; Green WN
J Biol Chem; 2008 Apr; 283(15):9659-65. PubMed ID: 17702741
[TBL] [Abstract][Full Text] [Related]
2. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
3. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
Matsuyama S; Matsumoto A
J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
5. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
Rupniak NM; Patel S; Marwood R; Webb J; Traynor JR; Elliott J; Freedman SB; Fletcher SR; Hill RG
Br J Pharmacol; 1994 Dec; 113(4):1487-93. PubMed ID: 7889306
[TBL] [Abstract][Full Text] [Related]
7. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
8. Epibatidine is a nicotinic analgesic.
Qian C; Li T; Shen TY; Libertine-Garahan L; Eckman J; Biftu T; Ip S
Eur J Pharmacol; 1993 Dec; 250(3):R13-4. PubMed ID: 8112391
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
10. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
[TBL] [Abstract][Full Text] [Related]
11. Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats.
McCallum SE; Caggiula AR; Booth S; Breese CR; Lee MJ; Donny EC; Leonard S; Sved AF
Psychopharmacology (Berl); 2000 May; 150(1):1-8. PubMed ID: 10867970
[TBL] [Abstract][Full Text] [Related]
12. The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain.
Belluardo N; Mudò G; Blum M; Cheng Q; Caniglia G; Dell'Albani P; Fuxe K
Brain Res Mol Brain Res; 1999 Dec; 74(1-2):98-110. PubMed ID: 10640680
[TBL] [Abstract][Full Text] [Related]
13. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
Free RB; Kaser DJ; Boyd RT; McKay DB
Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
16. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
[TBL] [Abstract][Full Text] [Related]
17. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
[TBL] [Abstract][Full Text] [Related]
18. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
19. The unusual nature of epibatidine responses at the alpha4beta2 nicotinic acetylcholine receptor.
Buisson B; Vallejo YF; Green WN; Bertrand D
Neuropharmacology; 2000 Oct; 39(13):2561-9. PubMed ID: 11044727
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
